Skip to main content
All lobbying filings

AVENUE SOLUTIONS

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical Company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • S 3019
    No Big Blockbuster Bailouts Act
 Lobbying activity 2
Health Issues

Issues related to prescription drugs

Medicare/Medicaid

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem